Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
The investigational therapy, MDX2003, is designed to go after cancer cells with a multi-pronged immune attack
While many cases are treatable, a subset can become highly aggressive, spreading to distant organs and resisting conventional therapies
Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
Move amid evidence of widespread reporting gaps
Workshop on ECG interpretation also marks launch of “Handbook on ECGs – Volume 2”
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
A brand from Opella will be part of the official NASA astronaut formulary
The inspection is now closed, and no regulatory action has been recommended
Subscribe To Our Newsletter & Stay Updated
